Wikidata

(Q61980684)

English

Observational Study on the Effect of NovoMix® 30, Levemir® or NovoRapid® (Alone or Combined) in Type 2 Diabetics Previously Treated With Anti-diabetic Medication

clinical trial

In more languages
default for all languages
No label defined

No description defined

Statements

short name
A1chieve® (English)
0 references
title
The Effect of NovoMix® 30, Levemir® or NovoRapid® (Alone or in Combination) in Subjects With Type 2 Diabetes Previously Treated With Other Anti-diabetic Medication. A 24-week, International, Prospective, Multi-centre, Open-labelled, Non-interventional Study (English)
0 references
country
Algeria
0 references
Argentina
0 references
Bangladesh
0 references
Egypt
0 references
India
0 references
Indonesia
0 references
Jordan
0 references
Malaysia
0 references
Mexico
0 references
Morocco
0 references
Pakistan
0 references
Philippines
0 references
Saudi Arabia
0 references
Singapore
0 references
Taiwan
0 references
Tunisia
0 references
Turkey
0 references
start time
November 2008
0 references
end time
March 2011
0 references
number of participants
66,726
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q61980684&oldid=2149186929"